Margins may also trend slightly higher to around 41.5%, plus or minus 100 basis points, according to guidance, supported by ...

Eswin’s capability in 12-inch wafers is seen as an important asset for China’s strategic drive towards semiconductor ...

(Reuters) -Shares of Applied Materials tumbled nearly 14% in premarket trading on Friday after the chip equipment maker ...

Hong Kong’s economy will expand by between 2 and 3 per cent this year as previously forecast despite worsening geopolitics, ...

Apple shares were up 0.1% in early premarket trading on Friday, even after Warren Buffett's Berkshire Hathaway trimmed its ...

In China, weak monthly data on retail sales and industrial production pointed to a broad-based slowdown. The reports add to pressure on Beijing to do more to rev u ...

JD.Com Inc. is stepping up its international ambitions with a playbook that closely resembles Amazon's approach to overseas ...

Chinese drugmaker Guangzhou Innogen Pharmaceutical had a strong debut in Hong Kong, cashing in on positive sentiment toward its flagship drug and Chinese biotech stocks in general.

However, management issued a more cautious outlook for the fourth quarter, guiding to total net revenue of $6.7 billion (plus or minus $500 million), non-GAAP gross margin of 48.1%, and non-GAAP ...

European markets pushed higher again on Friday, with London’s FTSE 100 smashing another record high at the open, yet the ...

Lynas Rare Earths shares (ASX:LYC) continued its impressive rally, closing up at the new peak of A$14.49, fueled by positive sentiment surrounding the rare earths market and strategic industry ...